肥満問題の重大とその経済的影響を考えると、研究、技術革新、実験への投資は非常に控えめです。たとえば、英国は、減量プログラムや公衆衛生キャンペーンなどの予防への取組みに費やす金額は年間10億ドル未満です。文脈で言えば、それが英国における肥満の社会的コストに占める割合はわずか1％程度にすぎません。特に大規模なプログラムの一部として使用された場合の介入技術の有効性をよりよく理解するには、より多くの資金が必要です。さまざまな治療法を試してみることをいとわないはずです。高品質のランダム化比較試験からの影響データは、多くの介入分野で入手するのが困難です。
拡大するパンデミックは、過去数十年にわたる社会とコミュニティの行動パターンの大きな変化を反映しています。遺伝子は体重増加に対する人の脆弱性を定義する役割を果たしますが、カロリー摂取量と運動がエネルギーバランスに影響を与えます。その結果、肥満のパンデミックは、社会の変化と世界的な食生活の革命によって引き起こされています。経済発展、工業化、都市化、および食品市場のグローバル化は、パンデミックを引き起こしていると考えられている要因のほんの一部にすぎません。
賃金が上昇し、人々がより都会的になるにつれて、複雑な炭水化物が豊富な食事は、脂質、飽和脂肪、お菓子などの割合が多い、より多様な食事に取って代わられます。同時に、世界中で仕事の形態が大きく変化し、肉体的に負担の少ない仕事が増えました。自動化された交通機関の使用の増加、家事の省力化、より受動的な余暇活動などは全て、運動不足の兆しを表すものです。
目次
1. Report Overview
1.1 Introduction to Anti-Obesity Drugs Market
1.2 Anti-Obesity Drugs Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 Rising Obesity Awareness to Fuel Market Growth
3.1.2 Growing Healthcare Expenditure Anticipated to Drive Market Growth
3.2 Restraints
3.2.1 Lack of Understanding
3.2.2 Lack of Insurance to Restrain Market Growth
3.2.3 Clinical Trial Enrolment Challenging Market Growth
3.3 Opportunities
3.3.1 Growing Obesity Consciousness Among Public to Offer Lucrative Growth Opportunities
3.3.2 COVID-19 Pandemic Anticipated to Boost Market Growth
3.3.3 Emerging Economies to Offer Lucrative Growth Prospects
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weaknesses
3.4.3 Opportunities
3.4.4 Threats
3.5 Porter’s Five Forces Analysis
3.5.1 Buyer Power
3.5.2 Supplier Power
3.5.3 Competitive Rivalry
3.5.4 Threat of Substitute
3.5.5 Threat of New Entrants
3.6 PEST Analysis
3.6.1 Political Factors Impacting Anti-Obesity Drugs Market
3.6.2 Economic Factors Impacting Anti-Obesity Drugs Market
3.6.3 Social Factors Impacting Anti-Obesity Drugs Market
3.6.4 Technological Factors Impacting Anti-Obesity Drugs Market
4 Anti-Obesity Drugs Market by Mechanism of Action
4.1 Incretin Mimetics/GLP-1 Agonists Segment Market Forecast, 2021-2031
4.1.1 Incretin Mimetics/GLP-1 Agonists Market Overview
4.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.2 Lipase Inhibitors Segment Market Forecast, 2021-2031
4.2.1 Lipase Inhibitors Market Overview
4.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.3 SNDRI’s Segment Market Forecast, 2021-2031
4.3.1 SNDRI’s Market Overview
4.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.4 Serotonin Receptor Agonists Segment Market Forecast, 2021-2031
4.4.1 Serotonin Market Overview
4.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.5 Sympathomimetic-GABA Receptor Agonists Segment Market Forecast, 2021-2031
4.5.1 Sympathomimetic-GABA Receptor Agonists Market Revenue, 2021-2031
4.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.6 Sympathomimetics Segment Market Forecast, 2021-2031
4.6.1 Sympathomimetic Market Overview
4.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.7 Others Segment Market Forecast, 2021-2031
4.7.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5 Anti-Obesity Drugs Market by Type
5.1 Prescription Drugs Segment Market Forecast, 2021-2031
5.1.1 Prescription Drugs Market Overview
5.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.2 OTC Drugs Segment Market Forecast, 2021-2031
5.2.1 OTC Drugs Market Overview
5.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6 Anti-Obesity Drugs Market by Duration
6.1 Short-Term Anti-Obesity Drugs Segment Market Forecast, 2021-2031
6.1.1 Short-Term Anti-Obesity Drugs Market Overview
6.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.2 Long-Term Anti-Obesity Drugs Segment Market Forecast, 2021-2031
6.2.1 Long-Term Anti-Obesity Drugs Market Overview
6.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7 Anti-Obesity Drugs Market by Distribution Channel
7.1 Hospitals Segment Market Forecast, 2021-2031
7.1.1 Hospitals Segment Market Overview
7.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.2 Retail Segment Market Forecast, 2021-2031
7.2.1 Retail Segment Market Overview
7.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.3 Online Segment Market Forecast, 2021-2031
7.3.1 Online Segment Market Overview
7.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8 Regional and Leading National Anti-Obesity Drugs Market Forecasts 2021-2031
8.1 Global Anti-Obesity Drugs Market by Region Forecast 2021-2031
8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
9 North America Anti-Obesity Drugs Market
9.1 North America Anti-Obesity Drugs Market by Country, Forecast 2021-2031
9.2 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action
9.3 North America Anti-Obesity Drugs Market Forecast by Type
9.4 North America Anti-Obesity Drugs Market Forecast by Duration
9.5 North America Anti-Obesity Drugs Market Forecast by Distribution Channel
9.6 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031
9.6.1 U.S. Anti-Obesity Drugs Market Overview
9.6.2 U.S. Anti-Obesity Drugs Market Forecast to 2031
9.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. Anti-Obesity Drugs Market Forecast, 2021-2031
9.7 Canada Anti-Obesity Drugs Market Forecast, 2021-2031
9.7.1 Canada Anti-Obesity Drugs Market Overview
9.7.2 Canada Anti-Obesity Drugs Market Forecast to 2031
9.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada Anti-Obesity Drugs Market Forecast, 2021-2031
10 Europe Anti-Obesity Drugs Market
10.1 Europe Anti-Obesity Drugs Market by Country, Forecast 2021-2031
10.2 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action
10.3 Europe Anti-Obesity Drugs Market Forecast by Type
10.4 Europe Anti-Obesity Drugs Market Forecast by Duration
10.5 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel
10.6 Germany Anti-Obesity Drugs Market Forecast, 2021-2031
10.6.1 Germany Anti-Obesity Drugs Market Overview
10.6.2 Germany Anti-Obesity Drugs Market Forecast to 2031
10.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany Anti-Obesity Drugs Market Forecast, 2021-2031
10.7 UK Anti-Obesity Drugs Market Forecast, 2021-2031
10.7.1 UK Anti-Obesity Drugs Market Overview
10.7.2 UK Anti-Obesity Drugs Market Forecast to 2031
10.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK Anti-Obesity Drugs Market Forecast, 2021-2031
10.8 France Anti-Obesity Drugs Market Forecast, 2021-2031
10.8.1 France Anti-Obesity Drugs Market Overview
10.8.2 France Anti-Obesity Drugs Market Forecast to 2031
10.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): France Anti-Obesity Drugs Market Forecast, 2021-2031
10.9 Italy Anti-Obesity Drugs Market Forecast, 2021-2031
10.9.1 Italy Anti-Obesity Drugs Market Overview
10.9.2 Italy Anti-Obesity Drugs Market Forecast to 2031
10.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy Anti-Obesity Drugs Market Forecast, 2021-2031
10.10 Spain Anti-Obesity Drugs Market Forecast, 2021-2031
10.10.1 Spain Anti-Obesity Drugs Market Overview
10.10.2 Spain Anti-Obesity Drugs Market Forecast to 2031
10.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain Anti-Obesity Drugs Market Forecast, 2021-2031
10.11 Russia Anti-Obesity Drugs Market Forecast, 2021-2031
10.11.1 Russia Anti-Obesity Drugs Market Overview
10.11.2 Russia Anti-Obesity Drugs Market Forecast to 2031
10.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Russia Anti-Obesity Drugs Market Forecast, 2021-2031
10.12 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031
10.12.1 Rest of Europe Anti-Obesity Drugs Market Overview
10.12.2 Rest of Europe Anti-Obesity Drugs Market Forecast to 2031
10.12.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031
11 Asia Pacific Anti-Obesity Drugs Market
11.1 Asia Pacific Anti-Obesity Drugs Market by Country, Forecast 2021-2031
11.2 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action
11.3 Asia Pacific Anti-Obesity Drugs Market Forecast by Type
11.4 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration
11.5 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel
11.6 Japan Anti-Obesity Drugs Market Forecast, 2021-2031
11.6.1 Japan Anti-Obesity Drugs Market Overview
11.6.2 Japan Anti-Obesity Drugs Market Forecast to 2031
11.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Anti-Obesity Drugs Market Forecast, 2021-2031
11.7 China Anti-Obesity Drugs Market Forecast, 2021-2031
11.7.1 China Anti-Obesity Drugs Market Overview
11.7.2 China Anti-Obesity Drugs Market Forecast to 2031
11.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): China Anti-Obesity Drugs Market Forecast, 2021-2031
11.8 India Anti-Obesity Drugs Market Forecast, 2021-2031
11.8.1 India Anti-Obesity Drugs Market Overview
11.8.2 India Anti-Obesity Drugs Market Forecast to 2031
11.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): India Anti-Obesity Drugs Market Forecast, 2021-2031
11.9 Australia Anti-Obesity Drugs Market Forecast, 2021-2031
11.9.1 Australia Anti-Obesity Drugs Market Overview
11.9.2 Australia Anti-Obesity Drugs Market Forecast to 2031
11.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Australia Anti-Obesity Drugs Market Forecast, 2021-2031
11.10 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031
11.10.1 South Korea Anti-Obesity Drugs Market Overview
11.10.2 South Korea Anti-Obesity Drugs Market Forecast to 2031
11.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Korea Anti-Obesity Drugs Market Forecast, 2021-2031
11.11 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031
11.11.1 South-East Asia Anti-Obesity Drugs Market Forecast to 2031
11.11.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031
11.12 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031
11.12.1 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast to 2031
11.12.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031
12 Latin America Anti-Obesity Drugs Market
12.1 Latin America Anti-Obesity Drugs Market by Country, Forecast 2021-2031
12.2 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action
12.3 Latin America Anti-Obesity Drugs Market Forecast by Type
12.4 Latin America Anti-Obesity Drugs Market Forecast by Duration
12.5 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel
12.6 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031
12.6.1 Brazil Anti-Obesity Drugs Market Overview
12.6.2 Brazil Anti-Obesity Drugs Market Forecast to 2031
12.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil Anti-Obesity Drugs Market Forecast, 2021-2031
12.7 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031
12.7.1 Mexico Anti-Obesity Drugs Market Overview
12.7.2 Mexico Anti-Obesity Drugs Market Forecast to 2031
12.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico Anti-Obesity Drugs Market Forecast, 2021-2031
12.8 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031
12.8.1 Rest of Latin America Anti-Obesity Drugs Market Forecast to 2031
12.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031
13 Middle East and Africa Anti-Obesity Drugs Market
13.1 Middle East and Africa Anti-Obesity Drugs Market by Country, Forecast 2021-2031
13.2 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action
13.3 MEA Anti-Obesity Drugs Market Forecast by Type
13.4 MEA Anti-Obesity Drugs Market Forecast by Duration
13.5 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel
13.6 GCC Anti-Obesity Drugs Market Forecast, 2021-2031
13.6.1 GCC Anti-Obesity Drugs Market Overview
13.6.2 GCC Anti-Obesity Drugs Market Forecast to 2031
13.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC Anti-Obesity Drugs Market Forecast, 2021-2031
13.7 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031
13.7.1 South Africa Anti-Obesity Drugs Market Overview
13.7.2 South Africa Anti-Obesity Drugs Market Forecast to 2031
13.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa Anti-Obesity Drugs Market Forecast, 2021-2031
13.8 Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031
13.8.1 Rest of MEA Anti-Obesity Drugs Market Overview
13.8.2 Rest of MEA Anti-Obesity Drugs Market Forecast to 2031
13.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031
14 Company Profiles
14.1 Bristol-Myers Squibb
14.1.1 Company Snapshot
14.1.2 Company Overview
14.1.3 Financial Analysis
14.1.4 Product Benchmarking
14.1.5 Recent Developments
14.2 Currax Pharmaceuticals LLC
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Product Benchmarking
14.2.4 Recent Developments
14.3 Eisai Co. Ltd
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.4 Product Benchmarking
14.3.5 Recent Developments
14.4 GlaxoSmithKline PLC
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.4 Product Benchmarking
14.4.5 Recent Developments
14.5 Merck & Co. Inc.
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.4 Product Benchmarking
14.5.5 Recent Developments
14.6 Novo Nordisk A/S
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.4 Product Benchmarking
14.6.5 Recent Developments
14.7 Pfizer Inc.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.4 Product Benchmarking
14.7.5 Recent Developments
14.8 Rhythm Pharmaceuticals
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.4 Product Benchmarking
14.8.5 Recent Developments
14.9 Vivus Inc.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.4 Product Benchmarking
14.9.5 Recent Developments
14.10 ERX Pharmaceuticals
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Product Benchmarking
14.11 CohBar
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.4 Product Benchmarking
Recent Developments
14.12 Carmot Therapeutics
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Product Benchmarking
14.13 YSOPIA Bioscience
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Product Benchmarking
14.14 Gelesis
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Product Benchmarking
14.15 Scohia Pharma, Inc.
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Product Benchmarking
14.16 Hanmi Pharmaceutical, Co., Ltd.
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.4 Product Benchmarking
14.17 Saniona
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Product Benchmarking
15 Conclusion and Recommendations
15.1 Concluding Remarks
15.2 Recommendations for Market Players
List of Tables
Table 1 Global Anti-Obesity Drugs Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
Table 2 Global Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 3 Global Anti-Obesity Drugs Market Forecast for Incretin Mimetics/GLP-1 Agonists Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 4 Global Anti-Obesity Drugs Market Forecast for Incretin Mimetics/GLP-1 Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 5 Global Anti-Obesity Drugs Market Forecast for Incretin Mimetics/GLP-1 Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 6 Global Anti-Obesity Drugs Market Forecast for Incretin Mimetics/GLP-1 Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 7 Global Anti-Obesity Drugs Market Forecast for Incretin Mimetics/GLP-1 Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 8 Global Anti-Obesity Drugs Market Forecast for Lipase Inhibitors Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 9 Global Anti-Obesity Drugs Market Forecast for Lipase Inhibitors Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Global Anti-Obesity Drugs Market Forecast for Lipase Inhibitors Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Global Anti-Obesity Drugs Market Forecast for Lipase Inhibitors Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Global Anti-Obesity Drugs Market Forecast for Lipase Inhibitors Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Global Anti-Obesity Drugs Market Forecast for SNDRI's Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 14 Global Anti-Obesity Drugs Market Forecast for SNDRI's Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 15 Global Anti-Obesity Drugs Market Forecast for SNDRI's Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 16 Global Anti-Obesity Drugs Market Forecast for SNDRI's Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 17 Global Anti-Obesity Drugs Market Forecast for SNDRI's Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 18 Global Anti-Obesity Drugs Market Forecast for Serotonin Receptor Agonists Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 19 Global Anti-Obesity Drugs Market Forecast for Serotonin Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 20 Global Anti-Obesity Drugs Market Forecast for Serotonin Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 21 Global Anti-Obesity Drugs Market Forecast for Serotonin Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 22 Global Anti-Obesity Drugs Market Forecast for Serotonin Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 23 Global Anti-Obesity Drugs Market Forecast for Sympathomimetic-GABA Receptor Agonists Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 24 Global Anti-Obesity Drugs Market Forecast for Sympathomimetic-GABA Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 25 Global Anti-Obesity Drugs Market Forecast for Sympathomimetic-GABA Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 26 Global Anti-Obesity Drugs Market Forecast for Sympathomimetic-GABA Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 27 Global Anti-Obesity Drugs Market Forecast for Sympathomimetic-GABA Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 28 Global Anti-Obesity Drugs Market Forecast for Sympathomimetics Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 29 Global Anti-Obesity Drugs Market Forecast for Sympathomimetics Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 30 Global Anti-Obesity Drugs Market Forecast for Sympathomimetics Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 31 Global Anti-Obesity Drugs Market Forecast for Sympathomimetics Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 32 Global Anti-Obesity Drugs Market Forecast for Sympathomimetics Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 33 Global Anti-Obesity Drugs Market Forecast for Others Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 34 Global Anti-Obesity Drugs Market Forecast for Others Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 35 Global Anti-Obesity Drugs Market Forecast for Others Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 36 Global Anti-Obesity Drugs Market Forecast for Others Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 37 Global Anti-Obesity Drugs Market Forecast for Others Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 38 Global Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 39 Global Anti-Obesity Drugs Market Forecast for Prescription Drugs Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 40 Global Anti-Obesity Drugs Market Forecast for Prescription Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 41 Global Anti-Obesity Drugs Market Forecast for Prescription Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 42 Global Anti-Obesity Drugs Market Forecast for Prescription Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 43 Global Anti-Obesity Drugs Market Forecast for Prescription Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 44 Global Anti-Obesity Drugs Market Forecast for OTC Drugs Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 45 Global Anti-Obesity Drugs Market Forecast for OTC Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 46 Global Anti-Obesity Drugs Market Forecast for OTC Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 47 Global Anti-Obesity Drugs Market Forecast for OTC Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 48 Global Anti-Obesity Drugs Market Forecast for OTC Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 49 Global Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 50 Global Anti-Obesity Drugs Market Forecast for Short-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 51 Global Anti-Obesity Drugs Market Forecast for Short-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 52 Global Anti-Obesity Drugs Market Forecast for Short-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 53 Global Anti-Obesity Drugs Market Forecast for Short-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 54 Global Anti-Obesity Drugs Market Forecast for Short-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 55 Global Anti-Obesity Drugs Market Forecast for Long-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 56 Global Anti-Obesity Drugs Market Forecast for Long-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 57 Global Anti-Obesity Drugs Market Forecast for Long-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 58 Global Anti-Obesity Drugs Market Forecast for Long-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 59 Global Anti-Obesity Drugs Market Forecast for Long-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 60 Global Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 61 Global Anti-Obesity Drugs Market Forecast for Hospitals Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 62 Global Anti-Obesity Drugs Market Forecast for Hospitals Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 63 Global Anti-Obesity Drugs Market Forecast for Hospitals Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 64 Global Anti-Obesity Drugs Market Forecast for Hospitals Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 65 Global Anti-Obesity Drugs Market Forecast for Hospitals Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 66 Global Anti-Obesity Drugs Market Forecast for Retail Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 67 Global Anti-Obesity Drugs Market Forecast for Retail Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 68 Global Anti-Obesity Drugs Market Forecast for Retail Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 69 Global Anti-Obesity Drugs Market Forecast for Retail Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 70 Global Anti-Obesity Drugs Market Forecast for Retail Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 71 Global Anti-Obesity Drugs Market Forecast for Online Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 72 Global Anti-Obesity Drugs Market Forecast for Online Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 73 Global Anti-Obesity Drugs Market Forecast for Online Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 74 Global Anti-Obesity Drugs Market Forecast for Online Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 75 Global Anti-Obesity Drugs Market Forecast for Online Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 76 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%)
Table 77 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 78 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 79 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 80 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 81 North America Anti-Obesity Drugs Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 82 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 83 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 84 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 85 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 86 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 87 North America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 88 North America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 89 North America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 90 North America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 91 North America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 92 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 93 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 94 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 95 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 96 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 97 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 98 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 99 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 100 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 101 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 102 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 103 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 104 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 105 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 106 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 107 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 108 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 109 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 110 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 111 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 112 Europe Anti-Obesity Drugs Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 113 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 114 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 115 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 116 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 117 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 118 Europe Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 119 Europe Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 120 Europe Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 121 Europe Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 122 Europe Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 123 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 124 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 125 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 126 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 127 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 128 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 129 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 130 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 131 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 132 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 133 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 134 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 135 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 136 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 137 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 138 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 139 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 140 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 141 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 142 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 143 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 144 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 145 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 146 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 147 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 148 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 149 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 150 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 151 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 152 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 153 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 154 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 155 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 156 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 157 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 158 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 159 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 160 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 161 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 162 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 163 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 164 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 165 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 166 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 167 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 168 Asia Pacific Anti-Obesity Drugs Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 169 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 170 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 171 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 172 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 173 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 174 Asia Pacific Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 175 Asia Pacific Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 176 Asia Pacific Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 177 Asia Pacific Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 178 Asia Pacific Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 179 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 180 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 181 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 182 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 183 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 184 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 185 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 186 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 187 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 188 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 189 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 190 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 191 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 192 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 193 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 194 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 195 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 196 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 197 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 198 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 199 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 200 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 201 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 202 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 203 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 204 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 205 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 206 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 207 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 208 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 209 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 210 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 211 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 212 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 213 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 214 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 215 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 216 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 217 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 218 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 219 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 220 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 221 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 222 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 223 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 224 Latin America Anti-Obesity Drugs Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 225 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 226 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 227 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 228 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 229 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 230 Latin America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 231 Latin America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 232 Latin America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 233 Latin America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 234 Latin America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 235 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 236 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 237 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 238 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 239 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 240 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 241 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 242 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 243 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 244 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 245 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 246 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 247 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 248 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 249 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 250 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 251 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 252 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 253 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 254 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 255 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 256 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 257 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 258 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 259 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 260 MEA Anti-Obesity Drugs Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 261 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 262 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 263 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 264 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 265 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 266 MEA Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 267 MEA Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 268 MEA Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 269 MEA Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 270 MEA Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 271 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 272 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 273 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 274 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 275 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 276 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 277 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 278 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 279 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 280 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 281 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 282 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 283 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 284 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 285 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 286 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 287 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 288 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 289 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 290 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 291 Rest of MEA Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 292 Rest of MEA Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 293 Rest of MEA Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 294 Rest of MEA Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 295 Rest of MEA Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 296 Bristol-Myers Squibb: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 297 Bristol-Myers Squibb: Product Benchmarking
Table 298 Bristol-Myers Squibb: Recent Developments
Table 299 Currax Pharmaceuticals LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 300 Currax Pharmaceuticals LLC: Product Benchmarking
Table 301 Currax Pharmaceuticals LLC: Recent Developments
Table 302 Eisai Co. Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 303 Eisai Co. Ltd: Product Benchmarking
Table 304 Eisai Co. Ltd: Recent Developments
Table 305 GlaxoSmithKline PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 306 GlaxoSmithKline PLC: Product Benchmarking
Table 307 GlaxoSmithKline PLC: Recent Developments
Table 308 Merck & Co. Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 309 Merck & Co. Inc.: Product Benchmarking
Table 310 Merck & Co. Inc.: Recent Developments
Table 311 Novo Nordisk A/S: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 312 Novo Nordisk A/S: Product Benchmarking
Table 313 Novo Nordisk A/S: Recent Developments
Table 314 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 315 Pfizer Inc.: Product Benchmarking
Table 316 Pfizer Inc.: Recent Developments
Table 317 Rhythm Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 318 Rhythm Pharmaceuticals: Product Benchmarking
Table 319 Rhythm Pharmaceuticals: Recent Developments
Table 320 Vivus Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 321 Vivus Inc.: Product Benchmarking
Table 322 Vivus Inc.: Recent Developments
Table 323 ERX Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 324 ERX Pharmaceuticals: Product Benchmarking
Table 325 CohBar: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 326 CohBar: Product Benchmarking
Table 327 CohBar: Recent Developments
Table 328 Carmot Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 329 Carmot Therapeutics: Product Benchmarking
Table 330 YSOPIA Bioscience: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 331 YSOPIA Bioscience: Product Benchmarking
Table 332 Gelesis: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 333 Gelesis: Product Benchmarking
Table 334 Scohia Pharma, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 335 Scohia Pharma, Inc.: Product Benchmarking
Table 336 Hanmi Pharmaceutical, Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 337 Hanmi Pharmaceutical, Co., Ltd.: Product Benchmarking
Table 338 Saniona: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 339 Saniona: Product Benchmarking
?
List of Figures
Figure 1 Global Anti-Obesity Drugs Market: Market Segmentation
Figure 2 Global Anti-Obesity Drugs Market Attractiveness Index
Figure 3 Global Anti-Obesity Drugs Market: DROC
Figure 4 Global Anti-Obesity Drugs Market: SWOT Analysis
Figure 5 Porter’s Analysis
Figure 6 PEST Analysis
Figure 7 Global Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR %)
Figure 8 Global Anti-Obesity Drugs Market Share Forecast by Mechanism of Action, 2021, 2026, 2031 (%)
Figure 9 Global Anti-Obesity Drugs Market for Incretin Mimetics/GLP-1 Agonists Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 10 Global Anti-Obesity Drugs Market for Incretin Mimetics/GLP-1 Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 11 Global Anti-Obesity Drugs Market for Incretin Mimetics/GLP-1 Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 12 Global Anti-Obesity Drugs Market for Incretin Mimetics/GLP-1 Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 13 Global Anti-Obesity Drugs Market for Incretin Mimetics/GLP-1 Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 14 Global Anti-Obesity Drugs Market for Lipase Inhibitors Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 15 Global Anti-Obesity Drugs Market for Lipase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 16 Global Anti-Obesity Drugs Market for Lipase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 17 Global Anti-Obesity Drugs Market for Lipase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 18 Global Anti-Obesity Drugs Market for Lipase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 19 Global Anti-Obesity Drugs Market for SNDRI’s Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 20 Global Anti-Obesity Drugs Market for SNDRI’s Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 21 Global Anti-Obesity Drugs Market for SNDRI’s Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 22 Global Anti-Obesity Drugs Market for SNDRI’s Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 23 Global Anti-Obesity Drugs Market for SNDRI’s Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 24 Global Anti-Obesity Drugs Market for Serotonin Receptor Agonists Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 25 Global Anti-Obesity Drugs Market for Serotonin Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 26 Global Anti-Obesity Drugs Market for Serotonin Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 27 Global Anti-Obesity Drugs Market for Serotonin Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 28 Global Anti-Obesity Drugs Market for Serotonin Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 29 Global Anti-Obesity Drugs Market for Sympathomimetic-GABA Receptor Agonists Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 30 Global Anti-Obesity Drugs Market for Sympathomimetic-GABA Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 31 Global Anti-Obesity Drugs Market for Sympathomimetic-GABA Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Sh
